PPA
ALPN

Parametric Portfolio Associates’s Alpine Immune Sciences Inc ALPN Stock Holding History

Parametric Portfolio Associates’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,875
Closed -$151K – 3782
2021
Q4 		$151K Buy
+10,875
New +$135K ﹤0.01% 3482

Other funds holding ALPN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Parametric Portfolio Associates's ALPN Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Alpine Immune Sciences Inc (ALPN) in Q1 2022, closing a stake of 10,875 shares — an estimated $151K sold.

Parametric Portfolio Associates first reported a position in ALPN in Q4 2021 and held it in 1 quarter. The position peaked at $151K in Q4 2021. 56 funds tracked by Wall St. Rank hold ALPN as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Alpine Immune Sciences Inc position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 10,875 Alpine Immune Sciences Inc shares in Q1 2022, an estimated $151K.
  • Parametric Portfolio Associates first reported a position in Alpine Immune Sciences Inc in Q4 2021 and held it in 1 quarter.
  • Parametric Portfolio Associates's Alpine Immune Sciences Inc position peaked at $151K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.